What uterine size in patients with adenomyosis warrants surgical intervention?

For patients with adenomyosis, surgical intervention is generally recommended if the uterus measures more than 10 cm in longitudinal diameter, more than 8 cm in transverse diameter, and approximately more than 6 cm in anteroposterior diameter—and especially if accompanied by symptomatic discomfort. If symptoms are present, prompt medical consultation is advised.

A significantly enlarged uterus typically indicates more advanced disease, characterized by an increased number of ectopic endometrial glands and stroma within the myometrium. This leads to myometrial thickening and uterine enlargement, resulting in more pronounced symptoms and a substantial impact on the patient’s quality of life. When the uterus exceeds these dimensions—longitudinal diameter >10 cm, transverse diameter >8 cm, and anteroposterior diameter ≈6 cm—and is associated with symptoms such as dysmenorrhea, menorrhagia, or prolonged menstrual periods, and when pharmacologic therapy proves ineffective, surgical management is usually indicated. The specific procedure—such as myomectomy (adenomyoma excision) or hysterectomy—should be selected based on individual clinical circumstances.

If uterine enlargement is mild—i.e., not exceeding the size of a 12-week gestational uterus—and symptoms remain minimal with negligible impact on daily life, conservative management—including pharmacologic therapy—may be attempted initially. Close monitoring of disease progression is essential, and surgery can be deferred for the time being. Under physician guidance, patients may use medications such as danazol capsules, gestrinone capsules, or norethisterone tablets to alleviate symptoms.

In daily life, patients are encouraged to actively cooperate with treatment and maintain healthy lifestyle habits—including a light, balanced diet and regular sleep patterns—to support recovery.